Merck to pay $950 million to settle Vioxx investigation

November 23, 2011
Los Angeles Times
The Associated Press

The Justice Department said Tuesday that drug maker Merck & Co. will pay $950 million to resolve investigations into its marketing of the painkiller Vioxx.

The agency said Merck would pay $321.6 million in criminal fines and $628.4 million as a civil settlement agreement. It will also plead guilty to a misdemeanor charge that it marketed Vioxx as a treatment for rheumatoid arthritis before getting Food and Drug Administration approval. Read more

Also In The News

Tell Us Your Thoughts

How do you feel about having to pay more than everyone else for your medication? Tell us your story. **By filling out this form you are giving RxRights permission to use your comments to help build support for safe, affordable drug importation.**